Skip to main content

DuPont settles with Chemours

2nd February 2021

Submitted by:

Andrew Warmington

DuPont, its spin-off company Chemours, and Corteva, which unites DuPont’s and Dow’s former agrochemicals businesses, have agreed a settlement on all legal disputes concerning per- and polyfluoroalkyl substances (PFAS) arising out of the spin-off of Chemours in 2015.

Under this, DuPont (with Corteva) and Chemours will split certain qualified expenses incurred equally for up to 20 years and up to $4 billion. DuPont’s 50% will be limited to $2 billion. In addition, they will establish a $1 billion maximum escrow account for potential future PFAS liabilities over eight years, again on a 50-50 basis. Based on $670 million settlement between DuPont and Chemours in West Virginia in 2017, one financial analyst has estimated total PFAS legal liability for all three firms at $5.2 billion is litigation and $1.3 billion is cleanup costs.

“The agreement will provide a measure of security and certainty for each company and our respective shareholders using a transparent process to address and resolve any potential future legacy PFAS matters,” the three companies’ CEOs said in a joint statement.

This replaces an agreement on perfluorooctanoic acid (PFOA) made between DuPont and Chemours in 2017 and a subsequent amendment to the Chemours separation agreement. The three have also agreed to resolve ongoing PFOA litigation in Ohio, bar one case against DuPont that is currently pending appeal. The $83 million cost will be split $27 million each to DuPont and Corteva and $29 million to Chemours.

PFASs, including PFOA, are used in multiple applications, including non-stick and waterproof coatings, lubricants and foams for tackling fires. Over many decades, they have been discharged into multiple waterways in the US, which has no federal and few state limits. They have been linked to health problems like cancers of many types, organ failures and hormone disruptions, leading to multi-billion dollar lawsuits.

The spin-off of Chemours, which includes DuPont’s former fluourochemicals business, addressed legacy liabilities but the firms interpreted the terms differently. In 2019, Chemours sued DuPont, claiming that its estimates for the liability it would incur were “spectacularly wrong” and that DuPont unfairly dominated the separation proceedings.

The lawsuit was dismissed in 2020, a judge finding the separation agreement valid and ordering the firms to go to arbitration. The deal was agreed shortly before arbitration could take place. It does not remove Chemours’ obligations to indemnify it under the separation agreement, which was the initial cause of the disagreement.

Subsequently, DuPont announced the preliminary results of its exchange offer that will see its former nutrition and biosciences (N&B) business merge with IFF. The company will accept the offer, subject to certain conditions and the final exchange ratio is 0.718 of a share in N&B for one in DuPont. During the period of the offer, which ended on 29 January, nearly 370 million DuPont shares were tendered.

DuPont has also agreed to sell its Clean Technologies business for $510 million to a private equity consortium of BroadPeak Global, Asia Green Fund and the Saudi Arabian Industrial Investments Company. This is expected to close in Q2, subject to customary closing conditions and regulatory approvals.

DuPont Clean Technologies dates back to 1925. It offers catalyst and process technologies to regenerate sulfuric acid, hydroprocessing technology to desulfurise motor fuels, alkylation technology for clean gasoline and air pollution control systems for refineries and chemical facilities, plus related services.

UPL to split out specialities

Indian agrochemicals giant UPL has announced plans to transfer its speciality chemicals business, including agrochemical

Submitted by:

Andrew Warmington

AI for SAPs

Together with Algo Artis, Japan’s Nippon Shokubai has developed an algorithm-based means for the production

Submitted by:

Andrew Warmington

Nippon Shokubai's API Facility in Japan

Nucleic acid API boost

Nippon Shokubai is to expand its GMP capacity for nucleic APIs tenfold It will install

Submitted by:

Andrew Warmington

Flamma's facility in Dalian

Flamma opens in China

Italian CDMO Flamma Group has officially opened its new cGMP plant at Dalian, China, where

Submitted by:

Andrew Warmington

GL Chemtec has opened a new kilo lab

GL Chemtec completes kilo lab

CDMO GL Chemtec has announced the completion of a cGMP kilo lab at Oakville, Ontario

Submitted by:

Andrew Warmington

Sterling's facility at Deeside, UK

CDMOs in ADC investments

Five CDMOs across the world have separately announced investments in antibody-drug conjugates (ADCs). Piramal Pharma is

Submitted by:

Andrew Warmington

Afyren Neoxy plant

Milestones for two greentech firms

Afyren has achieved continuous production at its Afyren Neoxy plant at Clermont-Ferrand (pictured)

Submitted by:

Andrew Warmington

Origin by Ocean derives its materials from sargassum

CABB in algae biorefinery deal

CABB has agreed a strategic partnership to establish a first-in-kind algae biorefinery at its site at Kokkola

Submitted by:

Andrew Warmington

First waste-based biosurfactants

Belgian start-up AmphiStar has launched what it claims are the first fully upcycled biobased surfactants

Submitted by:

Andrew Warmington

Aether to supply Seqens

Indian firm Aether Industries has entered into a manufacturing agreement with Chemoxy International, a UK-based

Submitted by:

Andrew Warmington

New model for biocatalysts

BASF, the Austrian Research Centre of Industrial Biotechnology (ACIB) and the University of Graz in

Submitted by:

Andrew Warmington

CBE JU funds 31 more projects

The Circular Bio-based Europe Joint Undertaking (CBE JU), a €2 billion partnership between the EU

Submitted by:

Andrew Warmington

Ribbon cutting ceremony at Lubrizol's new office

Lubrizol opens London office

Lubrizol has opened a new office in Hammersmith, London. This will be home to a

Submitted by:

Andrew Warmington

Sudarshan to buy Heubach

India’s Sudarshan Chemical Industries (SCIL) has entered into a definitive agreement to acquire the Heubach

Submitted by:

Andrew Warmington

Alliance in natural fragrances

Sensegen, a US-based specialist in biotech-enabled fragrances, notably a new class of natural musk raw

Submitted by:

Andrew Warmington

Croda breaks ground in China

Croda International has broken ground for a low-carbon, multi-purpose production facility on a greenfield site

Submitted by:

Andrew Warmington

CCT collaboration for Givaudan

Flavours and fragrances giant Givaudan has agreed a research collaboration for the development of sustainable

Submitted by:

Andrew Warmington

REACH Authorisation

Candidate List ‘reaches’ 250

The European Chemicals Agency (ECHA) has added three more substances to the Candidate List of

Submitted by:

Andrew Warmington

Staff at Brenntag's newly acquired Czech site

CO2-free distribution site first

Brenntag has officially inaugurated what it claims to be the first CO2-emission-free chemical distribution site

Submitted by:

Andrew Warmington